Arava
Arava is a disease-modifying antirheumatic drug (DMARD) used primarily in the treatment of rheumatoid arthritis. It works by reducing inflammation and slowing the progression of joint damage, thereby improving symptoms such as pain, swelling, and stiffness. Its oral formulation offers a convenient treatment option for patients seeking long-term management of autoimmune joint conditions.
The mechanism of action of Arava centers on its inhibition of dihydroorotate dehydrogenase, an enzyme crucial for de novo pyrimidine synthesis in rapidly dividing cells, including activated lymphocytes. By interfering with this pathway, leflunomide reduces the proliferation of immune cells responsible for the inflammatory process in rheumatoid arthritis, which in turn helps control disease activity and joint destruction.
Patients typically start Arava with a loading dose to achieve therapeutic levels quickly, followed by a maintenance dose once daily. Regular monitoring is essential, as the drug has a long half-life and can remain in the body for an extended period. Liver function tests and complete blood counts are usually performed periodically, given the potential for hepatotoxicity and hematologic abnormalities.
Side effects associated with Arava can include diarrhea, elevated liver enzymes, and hair thinning, among others. More serious adverse effects, although less common, involve significant liver damage or severe infections due to immunosuppression. Patients are advised to report any signs of liver dysfunction, such as jaundice or persistent abdominal pain, to their healthcare provider immediately.
Despite these potential side effects, Arava remains a valuable option for patients who do not respond adequately to other DMARDs. Its ability to modify the course of rheumatoid arthritis can result in improved joint function and quality of life. With careful monitoring and adherence to dosing guidelines, Arava can be an effective component of a comprehensive rheumatoid arthritis management plan.
NOTE: The above information is for marketing purposes only and is not to be construed as medical advice. Seek advice for medications from a qualified physician.
The mechanism of action of Arava centers on its inhibition of dihydroorotate dehydrogenase, an enzyme crucial for de novo pyrimidine synthesis in rapidly dividing cells, including activated lymphocytes. By interfering with this pathway, leflunomide reduces the proliferation of immune cells responsible for the inflammatory process in rheumatoid arthritis, which in turn helps control disease activity and joint destruction.
Patients typically start Arava with a loading dose to achieve therapeutic levels quickly, followed by a maintenance dose once daily. Regular monitoring is essential, as the drug has a long half-life and can remain in the body for an extended period. Liver function tests and complete blood counts are usually performed periodically, given the potential for hepatotoxicity and hematologic abnormalities.
Side effects associated with Arava can include diarrhea, elevated liver enzymes, and hair thinning, among others. More serious adverse effects, although less common, involve significant liver damage or severe infections due to immunosuppression. Patients are advised to report any signs of liver dysfunction, such as jaundice or persistent abdominal pain, to their healthcare provider immediately.
Despite these potential side effects, Arava remains a valuable option for patients who do not respond adequately to other DMARDs. Its ability to modify the course of rheumatoid arthritis can result in improved joint function and quality of life. With careful monitoring and adherence to dosing guidelines, Arava can be an effective component of a comprehensive rheumatoid arthritis management plan.
NOTE: The above information is for marketing purposes only and is not to be construed as medical advice. Seek advice for medications from a qualified physician.
ARAVA
Leflunomide
Brand: ARAVA
Leflunomide
Brand: ARAVA
10mg
30 Tablet
30 Tablet
$16.87
